Nocion Therapeutics
PrivateLast Round
Early Stage
VC
Mar 13, 2026
Est. Valuation
$125M
Total Funding Raised
$166M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Nocion Therapeutics is a biopharmaceutical company developing a new class of small molecule charged sodium channel blockers, called nocions, to treat conditions such as chronic cough, pain, and itch.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nocion Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Nocion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 13, 2026 | ||||
| Series B Extension | Jan 7, 2026 | ||||
| Series B | Mar 4, 2024 | ||||
| Series A | Jan 25, 2021 | ||||
| Series A | Apr 17, 2019 | ||||
Seed | Jul 10, 2018 |
Nocion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| F-Prime Capital | Series B, Series B Extension, Series A |
| Mass General Brigham Innovation | Series B Extension, Series B, Series A |
| Mass General Brigham Ventures | Series B Extension |
| Osage University Partners | Series B, Series B Extension |
| BioInnovation Capital | Series B, Series A, Series B Extension |
| Monograph Capital | Series B, Series B Extension |
| Canaan Partners | Series B, Seed, Series A, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 7, 2026
$23M raised in Series B Extension round.
- Apr 28, 2025
Matthew Frankel, M.D., MBA appointed as Chief Medical Officer.
Nocion Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nocion Therapeutics's valuation, stock price, and market status.